Commercialization requires more than one discipline.
Clearpath brings together technology commercialization, intellectual property, market intelligence, venture development and industry engagement capabilities around a single objective: moving promising technology toward a defensible market outcome.
Justin Mahan | Founder and CEO
Justin is a retired U.S. Air Force Senior Noncommissioned Officer with experience spanning nuclear security, tactical communications and global engineering programs. Former Head of Technology Partnerships at a corporate consulting firm, supporting hundreds of companies spun out of or accelerated from federal labs and agencies. In that role he led initiatives supporting the Department of Defense, Department of Energy, Department of Homeland Security, NASA, defense primes and nonprofit innovation organizations.
Justin holds an MBA and brings firsthand experience assembling founding teams, developing commercialization pathways and building the industry relationships required to move technology from research to market.
The Clearpath bench
Clearpath draws on specialized commercialization, intellectual property, scientific, regulatory, venture and market expertise according to the technology and engagement objective.
- Technology transfer and licensing
- Patent strategy and IP evaluation
- Defense and dual-use commercialization
- Nanoscience and microsystems
- FDA and biotechnology development
- Venture investment and company formation
- Federal capture and nondilutive funding
- Market research and customer discovery
- IP brokerage and transaction support
- International and U.S. market entry